Related Experiment Video

Updated: Aug 19, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study

A Acquarolo1, T Urli, G Perone

  • 1Institute of Anesthesiology-Intensive Care, University of Brescia Spedali Civili, Piazzale Ospedali Civili 1, 25125 Brescia, Italy. a.acquarolo@tiscali.it

Intensive Care Medicine
|March 9, 2005
PubMed

Insights

A 3-day ampicillin-sulbactam prophylaxis significantly reduced early-onset pneumonia (EOP) in comatose, mechanically ventilated patients. This antibiotic strategy lowered EOP occurrence by 64%, suggesting a potential new preventative measure for critically ill patients.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Comatose, mechanically ventilated patients are at high risk for hospital-acquired infections, particularly pneumonia.
  • Early-onset pneumonia (EOP) in this vulnerable population contributes to increased morbidity and mortality.
  • Prophylactic antibiotic strategies are being explored to mitigate infection risk in intensive care units (ICUs).

Purpose of the Study:

  • To investigate the efficacy of a 3-day ampicillin-sulbactam prophylaxis in preventing early-onset pneumonia (EOP).
  • To assess the impact of this prophylaxis on critically ill, comatose, and mechanically ventilated patients.

Main Methods:

  • A single-center, prospective, randomized, open-label study was conducted.
  • Comatose mechanically ventilated patients with brain injury were randomized to receive either ampicillin-sulbactam prophylaxis plus standard care or standard care alone.
  • The primary endpoint was the occurrence of EOP.

Main Results:

  • The ampicillin-sulbactam prophylaxis group showed a statistically significant reduction in EOP.
  • EOP occurred in 21.0% of patients receiving prophylaxis versus 57.9% in the standard treatment group (P = 0.022).
  • This represents a 64% relative risk reduction in EOP, with a number needed to treat of three.

Conclusions:

  • A 3-day course of ampicillin-sulbactam prophylaxis effectively reduced the incidence of EOP in comatose, mechanically ventilated patients.
  • The findings support further investigation in larger multicenter trials to confirm mortality benefits and assess potential impacts on antibiotic resistance.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...